Docetaxel and Metastases to liver - a phase IV clinical study of FDA data

Summary:

Metastases to liver is reported as a side effect among people who take Docetaxel (docetaxel), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Herceptin, and have Breast cancer.

The phase IV clinical study analyzes which people have Metastases to liver when taking Docetaxel. It is created by eHealthMe based on reports of 79,811 people who have side effects when taking Docetaxel from the FDA, and is updated regularly.

What is Docetaxel?

Docetaxel has active ingredients of docetaxel. eHealthMe is studying from 79,875 Docetaxel users. Check the latest studies of Docetaxel.

What is Metastases to liver?

Metastases to liver (cancer spreads to liver) is found to be associated with 1,041 drugs and 999 conditions by eHealthMe. Check the latest studies of Metastases to liver.

On Jul, 04, 2026

79,811 people reported to have side effects when taking Docetaxel.
Among them, 741 people (0.93%) have Metastases to liver.

Could Docetaxel cause Metastases to liver?

Among these 741 people:

How long have people been on Docetaxel when they have Metastases to liver? *

Click here to view more results

What is the gender of people who have Metastases to liver when taking Docetaxel? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Docetaxel and have Metastases to liver?

- Check whether Metastases to liver is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Docetaxel:

Docetaxel (79,875 reports)

Metastases to liver treatments and more:

Metastases to liver (28,348 reports)

How severe was Metastases to liver and when was it recovered:

Metastases to liver in Docetaxel

Expand to all the drugs that have ingredients of docetaxel:

Metastases to liver and drugs with ingredients of docetaxel (1,334 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Docetaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Metastases to liver:

Metastases to liver (1,041 drugs)

Browse all the conditions that are associated with Metastases to liver:

Metastases to liver (999 conditions)

Related publications that referenced our studies

Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on docetaxel (the active ingredients of Docetaxel) and Docetaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.